Ruthee-lu Bayer is a Transplant Surgeon in Lake Success, New York. Dr. Bayer is rated as an Advanced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). Her top areas of expertise are Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.

Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is rated as an Advanced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration.

Erin Jou, MD is an attending physician at the Monter Cancer Center. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Jou is an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Jou s practice is solely dedicated to the treatment of patients with benign and malignant hematologic disorders where she focusses on providing compassionate, personalized, evidence-based multi-disciplinary care. She is involved in clinical research at Monter Cancer Center and actively enrolls patients in clinical trials. After graduating from the Pennsylvania State University, Dr. Jou earned her medical degree from Jefferson Medical College. She trained in Internal Medical and Hematology/Oncology at Montefiore Medical Center. Dr. Jou is an active member of the American Society of Hematology. Dr. Jou is rated as an Experienced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration.

An internationally known leader in hematology, A. Samer Al-Homsi, MD, MBA, is system chief of blood and marrow transplant and cellular therapy at the Northwell Health Cancer Institute, where he also serves as director of faculty and academic affairs in medical oncology.In his position, Dr. Al-Homsi treats patients in need of blood and marrow transplantation for blood cancers and other blood conditions. Dr. Al-Homsi attended medical school at Damascus University Faculty of Medicine, did his residency at Advocate Christ Medical Center in Illinois, and completed a fellowship at UMass Chan Medical School in Worcester, MA. He also received training and practiced in France. He came to Northwell from the Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, where he was executive director of transplantation and cellular therapy. His research efforts throughout his career have focused on innovations that lead to better patient care in blood and marrow transplantation.The poet Kahlil Gibran wrote that work is love made visible, and I believe medicine is love made visible, says Dr. Al-Homsi. Every patient has unique needs, based not just on their specific condition, but also on their cultural background, family situation, and the impact of their disease. We're fortunate at Northwell to have care delivered by a large team that's there to address all those aspects.Dr. Al-Homsi is looking forward to advancing more clinical research at Northwell's Feinstein Institutes for Medical Research and at Cold Spring Harbor Laboratory. That will likely facilitate the development of more therapies that can treat patients, he says, and in a way that's safer and more effective.Dr. Al-Homsi doesn't just focus on the physical effects of conditions like leukemia, lymphoma, and multiple myeloma with decades of patient care, he also knows the tremendous value of a deeper conversation about how cancer is affecting patients mental health and everyday function. His priority is to learn about the patient first and the disease second.That perspective on patient advocacy and approaching each interaction with compassion and love is the same now as it was when he first entered medical school, he recalls. I wanted my life to matter, and to make a difference, he says. I'm not trying to change the world, but I can change patients' lives. I can change their world, and that's incredibly rewarding and meaningful. Dr. Al is rated as an Experienced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Graft Versus Host Disease (GvHD), Multiple Myeloma, Adult T-Cell Leukemia, Chronic T-Cell Leukemia (CTCL), and Bone Marrow Transplant.

Steven L. Allen, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in benign and malignant hematology, he is the System Head for Benign Hematology for the Northwell Health Cancer Institute. As an attending physician at the Monter Cancer Center, Dr. Allen focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Allen has been the principal investigator for numerous drug trials and has collaborated with several basic science labs, resulting in over 150 publications. Among his many professional affiliations, he is most active with the American Society of Hematology, having served in numerous leadership positions and committees. In addition, he is a dedicated member of the American Society of Clinical Oncology, Empire State Hematology and Oncology Society, and the American College of Physicians. Dr. Allen earned his medical degree from the Johns Hopkins School of Medicine. He trained in internal medicine and hematology/oncology at New York Hospital-Weill Cornell Medical Center. Dr. Allen is rated as an Experienced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Leukemia, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration.

Jaime Londono is a Hematologist and an Oncologist in New Hyde Park, New York. Dr. Londono is rated as an Experienced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Myelodysplastic Syndrome (MDS), Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.

David Chitty, DO, MSc is an Attending physician at the Monter Cancer Center where he specializes in malignant hematology with a particular clinical interest in acute leukemias. Board certified in Internal Medicine and Medical Oncology, Dr. Chitty maintains an active practice where he focuses on compassionate, personalized, evidence-based multi-disciplinary care. Dr. Chitty is a graduate of the Northwell Health Medical Oncology Translational Research Fellowship program. Prior to his Hematology/Oncology Fellowship, Dr. Chitty completed a residency in Internal Medicine at Maimonides Medical Center in Brooklyn, NY. A graduate of Nova Southeastern University School of Osteopathic Medicine, Dr. Chitty also earned a Master s in Science degree at the University of Ottawa, Ottawa, Canada in Cellular and Molecular Medicine. His work and research in the fields of medicine and oncology have been published in various peer-reviewed journals.Currently, his primary research interest is in the development and implementation of novel measurable residual disease assays. This work will allow clinicians to better implement targeted therapies into clinical practice for patients with resistant or residual disease following initial treatment. In addition, Dr. Chitty was instrumental in COVID-19 related research and continues to help push forward our understanding of COVID-19 disease in patients with cancer. Dr. Chitty is rated as an Experienced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Acute Myeloid Leukemia (AML), Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia with Maturation, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Dr. Sarah J. Noor joined the dermatology faculty at Northwell in 2023 and serves as the Director of Diversity and Inclusion for the Department of Dermatology. She also is an Assistant Professor at the Zucker School of Medicine at Hofstra/Northwell.Prior to joining the group at Northwell, she was on faculty at Memorial Sloan Kettering Cancer Center where she primarily saw patients with cutaneous lymphomas and dermatologic adverse events to cancer therapies. During her time there, she served as an investigator on several clinical trials to develop novel treatment approaches to address symptoms from disease or disease treatment in cutaneous lymphomas and other malignancies. She also is interested in understanding racial differences in dermatologic adverse events to cancer therapies, and has been involved in efforts to increase patient diversity in clinical trials and community outreach initiatives.Dr. Noor continues to have a clinical and research interest in oncology and cutaneous lymphoma and participates in the multidisciplinary care of these patients. She also has a clinical interest in general and complex medical dermatology and enjoys serving a diverse adult and pediatric patient population. In her role as Director of Diversity and Inclusion, she will be leading several departmental initiatives including medical student and resident curricular efforts, improving patient access to dermatologic care, and community engagement.Dr. Noor earned her undergraduate and medical degree from the George Washington University. She completed her internship in Pediatrics at the Icahn School of Medicine at Mount Sinai and residency in Dermatology at New York Presbyterian Weill Cornell where she served as chief resident in her final year. She is a member of several dermatology organizations including the American Academy of Dermatology in which she is active committee member, the Women s Dermatologic Society, the Skin of Color Society, and the United States Cutaneous Lymphoma Consortium. Dr. Noor is rated as an Advanced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). Her top areas of expertise are Mycosis Fungoides, T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Lymphomatoid Papulosis.

Jasmine Zain is a Hematologist and an Oncologist in New York, New York. Dr. Zain is rated as an Advanced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). Her top areas of expertise are T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Mohammad Abdul-Hay is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Abdul-Hay is rated as an Advanced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Dilip Patel is a Hematologist Oncology specialist and a Hematologist in Greenvale, New York. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Congenital Antithrombin 3 Deficiency, Protein C Deficiency, Hereditary Resistance to Anti-Vitamin K, Protein S Deficiency, and Bone Marrow Aspiration.

Anita Kumar is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Kumar has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). Her top areas of expertise are Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Kumar is currently accepting new patients.

Sebastian Mayer is a Hematologist Oncology specialist and a Transplant Surgeon in New York, New York. Dr. Mayer is rated as an Experienced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Colonoscopy.

Markus Mapara is an Oncologist and a Hematologist in New York, New York. Dr. Mapara is rated as an Experienced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Bone Marrow Transplant, and Bone Marrow Aspiration.

Ran Reshef is a Hematologist and a Hematologist Oncology provider in New York, New York. Dr. Reshef is rated as an Experienced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Graft Versus Host Disease (GvHD), Multiple Myeloma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Steven Horwitz is an Oncologist in New York, New York. Dr. Horwitz is rated as a Distinguished provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration.

Miguel Perales is an Oncologist in New York, New York. Dr. Perales is rated as a Distinguished provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Chronic T-Cell Leukemia (CTCL), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Multiple Myeloma.

Alison Moskowitz is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Moskowitz is rated as a Distinguished provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). Her top areas of expertise are T-Cell Lymphoma, Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Andrew Zaretsky is a primary care provider, practicing in Internal Medicine in Bronx, New York. Dr. Zaretsky has been practicing medicine for over 44 years and is rated as an Experienced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Stroke, Lung Metastases, Ascariasis, and EGFR Positive Lung Cancer.

Myra Davila is a primary care provider, practicing in Geriatrics and Internal Medicine in Bronx, New York. Dr. Davila is rated as an Experienced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). Her top areas of expertise are Lung Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Ascariasis.